NCT03487211View on ClinicalTrials.gov

Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

February 26, 2020

Study Completion Date

February 26, 2020

Conditions
Fibromyalgia
Interventions
DRUG

Duloxetine

Duloxetine 30mg PO once daily for 1 week followed by an increase to 60mg PO once daily

DRUG

Escitalopram

Escitalopram 10mg PO once daily for 1 week followed by an increase to 20mg PO once daily

Trial Locations (1)

44000

Pakistan Institute of Medical Sciences, Islamabad

All Listed Sponsors
lead

Shaheed Zulfiqar Ali Bhutto Medical University

OTHER

NCT03487211 - Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia | Biotech Hunter | Biotech Hunter